中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US08222238B2 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species 有权
使用蝶啶衍生物治疗颅内压升高，继发性缺血以及与增加细胞毒活性氧水平相关的疾病

  • Patent Title: Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
  • Patent Title (中): 使用蝶啶衍生物治疗颅内压升高，继发性缺血以及与增加细胞毒活性氧水平相关的疾病
  • Application No.: US10549200
    Application Date: 2003-10-08
  • Publication No.: US08222238B2
    Publication Date: 2012-07-17
  • Inventor: Robert Doblhofer , Frank Tegtmeier
  • Applicant: Robert Doblhofer , Frank Tegtmeier
  • Applicant Address: DE Wurzburg
  • Assignee: Vasopharm Biotech GmbH
  • Current Assignee: Vasopharm Biotech GmbH
  • Current Assignee Address: DE Wurzburg
  • Agent Sam K. Tahmassebi
  • Priority: WOPCT/EP03/03096 20030325
  • International Application: PCT/EP03/11138 WO 20031008
  • International Announcement: WO2004/084906 WO 20041007
  • Main IPC: A61K31/50
  • IPC: A61K31/50 ;  A61K31/495 ;  A61K31/33 ;  A01N43/58 ;  A01N43/60 ;  A01N43/00
Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
Abstract:
The present invention relates to the use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species.
Abstract(Chinese):

本发明涉及蝶啶衍生物用于治疗增加的颅内压，二次缺血以及与增加的细胞毒性活性氧物质水平相关的病症的用途。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0